[View Original Text]

AIDOT (represented by Jeong Jae-hoon) announced on the 17^th of August that the Patent related to the 'Cerviray AI' has been registered as an 'Automatic Cervical Cancer Diagnosis 

System' in Japan and Indonesia.

The company explained that the artificial intelligence (AI) software analyzes and classifies the severity of cervical cancer from captured images, assisting doctors in their diagnoses.

An AIDOT representative stated, 'The Patent for our automatic cervical cancer diagnosis system encompasses the setup and operation of the Cerviray AI system. We have effectively protected the technology by completing Patent registrations not only in South Korea but also in China, Indonesia, and Japan.'

According to the company, AIDOT is currently in the process of receiving registration decisions for Cerviray-related Patents in key countries through the Patent Cooperation Treaty 

(PCT). By extensively safeguarding the unique features of AI-enabled lesion analysis and diagnostic assistance software in the field of cervical cancer screening, AIDOT is making its way into the global market.

The AIDOT representative stated, 'AIDOT is strategically entering different countries through Patent registrations and local clinical trials, while gaining recognition for the technological prowess and competitiveness of our product.'

Source: Money Today / 2023.08.17 / Reporter Lee Doo-ri